Tissue engineering is an emerging multidisciplinary field involving biology, medicine and engineering by restoring tissues and organs to transfer patients under laboratory conditions.
In the world, cartilage, bone, vascular, heart, breast, skin and liver are included in tissues generated via tissue engineering.
Cartilage which has a softer and more flexible matrix than bone tissue functions as partial-carrier in the body. Cartilage does not contain blood vessels. The chondrocytes are supplied by diffusion of nutrients through the matrix.
CaReS® used for the regeneration of cartilage restoration is a new concept for improvement of t-cartilage damages with surgical methods.
CaReS® is a new technology for surgical improvement of cartilage lesions (2,5-10 cm2). Licenced 3D-cell-collagen type I matrix provides a natural environment for collagen type II synthesis with highly controllable cell activity and functionality.
This product which is licenced by ARTHRO KINETICS Biotechnology GMBH is a three-dimensional matrix produced by fixing patient’s autologous cell culture in collagen type I.
In production, chondrocytes owned by the patient in the proliferation state are used. Diameter of transplant is determined according to injury in patient’s t.
CaReS® Know-How Transfer Agreement is signed between ONKIM Kök Hücre Teknolojileri A.Ş. and Arthro Kinetics Biotechnology GmbH addressing in Magnesitstrasse 1, A-3500 Krems an der Donau, Austria.
Tissue engineering provides personal treatment and solutions for problems in twenty first century.
It is announced to the public.
ONKIM & Arthro Kinetics Biotechnology GmbH
Yesterday 
Total
